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Summary Seventy seven patients with metastases from an invasive lobular carcinoma of the breast have been
compared with 72 consecutive metastatic ductal carcinomas. There was no difference in the metastatic free
interval between the two groups. A distinct pattern of clinical presentation of metastases was seen; hepatic
(P = 0.01) and peritoneal metastases (P =0.0003) occurred more commonly in lobular tumours. Bilateral
cancers were more common in the lobular group (P = 0.01). No difference was seen in terms ofmeningeal and
pulmonary metastases. Survival after metastases was significantly longer in patients with metastatic lobular
carcinoma (P = 0.02).
Differences in cell morphology, growth patterns and tissue
response allow for the division of invasive adenocarcinomas
of the breast into specific types (Gallagher, 1984); infiltrating
ductal (80%) and lobular (8-14.7%) carcinomas are the
commonest (Martinez & Azzopardi, 1979; Dixon et al.,
1982). The largest sub-group (65-68%) show no specific
characteristics and have been termed carcinoma NOS not
otherwise specified (Fisher et al., 1975) or ductal NOS
(Dixon et al., 1985). These histological differences have been
shown to have important influences upon prognosis (Gal-
lagher, 1984; Dixon et al., 1985). A study based on clinical
and post-mortem material (Harris et al., 1984) showed that
lobular carcinoma of the breast had a distinctly different
metastatic pattern to that seen in ductal carcinomas: lobular
types were associated with carcinomatous meningitis and
both peritoneal and retroperitoneal metastases of a diffuse
micro-nodular fashion; lung parenchymal metastases were
more common with ductal tumours. This series of lobular
carcinomas has been studied in an attempt to verify this
observation.
Patients and methods
One thousand patients with primary operable breast cancer
were treated in the Breast Unit at the City Hospital, Notting-
ham, between October 1973 and March 1983. Treatment
consisted of simple mastectomy, subcutaneous mastectomy or
lumpectomy followed by irradiation; no patient received
adjuvant systemic therapy. Using established criteria (Mar-
tinez & Azzopardi, 1979) two pathologists (I.O.E. and
C.W.E.) classified 118 of these as invasive lobular car-
cinomas. These case notes were reviewed and the following
data obtained: metastatic free interval, site of metastases and
survival after development of metastases. Distant metastatic
involvement was recorded as that which was determined
clinically during follow-up and verified by the relevant inves-
tigation. Port-mortem studies were not carried out. Seventy
seven patients (65%) with lobular tumours developed distant
metastases. These patients were compared with 72 con-
secutive metastatic ductal carcinomas that developed in the
first 134 patients of the Nottingham series.
Life table analysis was used to compare survival between
the two groups after the development of metastases. The x2
method was applied to determine statistical differences be-
tween two curves (Mantel, 1966). Fisher's exact test was used
to determine statistical differences between sites of metas-
tases.
Results
The median age at development of metastases was 56 years
(28-72 years) for invasive lobular tumours and 54 years
(37-70 years) for ductal carcinomas (not significant); medial
follow-up time for both groups was 72 months. The sites of
distant metastases as diagnosed clinically are shown in Table
I. Hepatic (P = 0.01) and peritoneal (0.0003) metastases were
detected significantly more often in lobular carcinomas. The
clinical presentation of the 14 lobular peritoneal metastases
included: retroperitoneal ureteric obstruction (3), large bowel
obstruction and perforation (1), 'linitis plastica' of the stom-
ach (2), small bowel obstruction (3), omental masses (5). The
six patients with obstructive/dysphagic symptoms underwent
laparotomy, the operative findings in each case being tiny
serosal nodules, widespread throughout the bowel. These
nodules were confluent at the site of obstruction.
No significant difference existed between the two patho-
logical types in terms of skeletal, pulmonary, pleural and
cerebral metastases. Eighteen of the 149 patients with metas-
tases developed metachronous contralateral cancers (12%),
14 of these occurred in the lobular group (P = 0.01).
Although there was no difference in the metastatic free
interval (Figure 1), survival from diagnosis of systemic me-
Table I Clinical metastatic pattern of77 invasive lobular carcinomas
compared with 72 invasive ductal carcinomas
Lobular (%) Ductal (%) P
Lung 18 (24) 16 (22) NS
Pleural 48 (63) 56 (78) NS
Bone 46 (60) 52 (72) NS
Liver 27 (35) 13 (18) 0.01
Peritoneum 14 (18) 1 (1) 0.0003
Salivary gland 2 ( 3) 0 ( 0) NS
Brain parenchyma I ( 1) 3 ( 4) NS
Leptomeninges 1 ( 1) 2 ( 3) NS
Opposite breast 14 (18) 4 ( 6) 0.01
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Figure 1 Distant metastatic free interval.
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Figure 2 Survival after development of distant metastases.
tastases was significantly longer (P = 0.021) in patients with
lobular carcinoma compared to ductal types (Figure 2).
Discussion
Although many reports (Viandana et al., 1973; Cifuentens &
Pickren, 1979; Amer (1982)) have addressed themselves to the
metastatic pattern of carcinoma of the breast, few have
considered potential differences between the histological sub-
types. The clinical and post-mortem study of (Harris et al.,
1984) showed that there was significant differences between
the metastatic sites of invasive lobular and ductal carcin-
omas. Lobular carcinoma demonstrated a tendency to pro-
duce clinically apparent diffuse meningeal involvement and
both peritoneal and retroperitoneal spread. The peritoneal
and retroperitoneal findings were said to be distinctive with
tiny nodules, tending to become confluent in lobular cases
comparing with large masses or nodules in ductal metastases;
lobular metastases rarely produced clinical manifestations.
Pulmonary parenchymal metastases were more frequently
detected in ductal types.
We confirm that lobular carcinoma has a different clinical
pattern of metastatic spread than that seen in ductal tu-
mours; clinically detectable peritoneal and hepatic metastases
are more frequent in lobular carcinoma. Unlike previous
studies (Harris et al., 1984) we were unable to demonstrate a
significant difference in pulmonary and meningeal metastases.
There was no difference in the metastatic free interval for the
two pathological types. Survival after metastatic appearance
was significantly longer in the group of patients with lobular
carcinoma.
Previous suggestions (Ashikari et al., 1973; Wheeler &
Enterline, 1976; Nielson et al., 1986) that bilateral cancers are
more frequently seen with lobular carcinomas are confirmed.
A possible explanation arises from the finding of lobular
carcinoma in situ (LCIS) in 66% of ipsilateral (Dixon et al.,
1982) and 35% of contralateral breasts (Urban, 1967) in
patients with invasive lobular carcinoma; LCIS lesions can
also progress to invasive carcinoma (Haagensen et al., 1978;
Rosen et al., 1978). These findings have important implica-
tions for the follow-up of patients with lobular carcinomas.
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